Search

everythinglearnresearchcommunity

for

Search:↓

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Some herbs and their components might help treat hair loss by affecting various biological pathways, but more research and regulation are needed.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Compounds from Angelica koreana roots, especially osthenol, could be effective for treating conditions like prostate disease and hair loss.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

Sleep, testosterone levels, and a specific enzyme activity affect skin oil production in women.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Finasteride effectively treats male pattern hair loss with a 1 mg daily dose.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Some hair loss can be treated, especially in women due to nutrition, but some types remain untreatable.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Testosterone helps human pancreatic cells increase insulin release.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Two people lost hair unexpectedly after getting a common hair loss treatment with a drug called Dutasteride.

New compounds show promise as nonsteroidal treatments for hair loss.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

The compounds tested could potentially treat hair loss and alopecia.

Finasteride increases CD8+ T cells in BPH tissues.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.